chr10-68431874-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001080449.3(DNA2):c.1971G>A(p.Thr657Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.045 in 1,608,528 control chromosomes in the GnomAD database, including 2,012 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 154 hom., cov: 32)
Exomes 𝑓: 0.046 ( 1858 hom. )
Consequence
DNA2
NM_001080449.3 synonymous
NM_001080449.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0640
Genes affected
DNA2 (HGNC:2939): (DNA replication helicase/nuclease 2) This gene encodes a member of the DNA2/NAM7 helicase family. The encoded protein is a conserved helicase/nuclease involved in the maintenance of mitochondrial and nuclear DNA stability. Mutations in this gene are associated with autosomal dominant progressive external ophthalmoplegia-6 (PEOA6) and Seckel syndrome 8. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 10-68431874-C-T is Benign according to our data. Variant chr10-68431874-C-T is described in ClinVar as [Benign]. Clinvar id is 257342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.064 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0597 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNA2 | NM_001080449.3 | c.1971G>A | p.Thr657Thr | synonymous_variant | 13/21 | ENST00000358410.8 | NP_001073918.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNA2 | ENST00000358410.8 | c.1971G>A | p.Thr657Thr | synonymous_variant | 13/21 | 1 | NM_001080449.3 | ENSP00000351185.3 | ||
DNA2 | ENST00000551118.6 | c.1971G>A | p.Thr657Thr | synonymous_variant | 13/17 | 5 | ENSP00000450393.3 | |||
DNA2 | ENST00000399179.6 | n.1971G>A | non_coding_transcript_exon_variant | 14/22 | 2 | ENSP00000382132.3 |
Frequencies
GnomAD3 genomes AF: 0.0376 AC: 5724AN: 152118Hom.: 155 Cov.: 32
GnomAD3 genomes
AF:
AC:
5724
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0451 AC: 11189AN: 247872Hom.: 390 AF XY: 0.0470 AC XY: 6323AN XY: 134462
GnomAD3 exomes
AF:
AC:
11189
AN:
247872
Hom.:
AF XY:
AC XY:
6323
AN XY:
134462
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0457 AC: 66586AN: 1456292Hom.: 1858 Cov.: 29 AF XY: 0.0466 AC XY: 33758AN XY: 724716
GnomAD4 exome
AF:
AC:
66586
AN:
1456292
Hom.:
Cov.:
29
AF XY:
AC XY:
33758
AN XY:
724716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0376 AC: 5724AN: 152236Hom.: 154 Cov.: 32 AF XY: 0.0380 AC XY: 2826AN XY: 74434
GnomAD4 genome
AF:
AC:
5724
AN:
152236
Hom.:
Cov.:
32
AF XY:
AC XY:
2826
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
62
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 08, 2016 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 14, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at